Browsing publications by Dr Mark Velangi

Newcastle Authors	Title	Year
Dr Roderick Skinner Dr Mark Velangi Dr Nicholas Bown	Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7	2008
Dr Tina Biss Dr Mark Velangi Dr John Hanley	Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature	2006
Dr Mark Velangi Dr Michael Reid Dr Roderick Skinner	Hybrid chemotherapy in two children with acute leukemia of ambiguous lineage	2006
Dr Mark Velangi Elizabeth Matheson Professor Andy Hall Dr Julie Irving	Detecting mismatch repair defects in myeloma	2005
Dr Mark Velangi Professor Graham Jackson	Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey	2005
Dr Mark Velangi	Reply to Saravanamuttu et al: Uptake of high dose therapy and peripheral blood stem cell transplantation in myeloma patients < 65 years - the role of the myeloma multi-disciplinary team	2005
Professor Graham Jackson Dr Mark Velangi	Only a minority of age eligible patients with myeloma undergo treatment with autologous transplantation. A population based study of the contributory factors. A combined survey on behalf of The Northern Ireland Regional Haematology Group (NIRHG) and The Newcastle Regional Haematology Group (NRHG)	2004
Professor Graham Jackson Dr Mark Velangi	Only a minority of myeloma patients aged under 65 years receive high-dose therapy with autologous transplantation	2004
Dr Mark Velangi Professor Graham Jackson Dr Penelope Taylor Professor Andy Hall Dr Julie Irving et al.	DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma	2003
Dr Mark Velangi Dr Michael Reid Dr Nicholas Bown Professor Graham Jackson Professor Stephen Proctor et al.	Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99	2002